Canada vs Papua New Guinea: Prevalence rate of hypertension in men aged 30-79
Canada
24.3
in 2019
Papua New Guinea
25.4
in 2019
Canada rank
192nd
Papua New Guinea rank
189th
Prevalence rate of hypertension in men aged 30-79 over time
- Canada
- Papua New Guinea
How they compare
Papua New Guinea currently reports 25.4 against 24.3 in Canada, a difference of 1.1.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Canada ahead.
Canada ranks 192nd and Papua New Guinea ranks 189th of 195 countries.
Canada has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Canada | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 33.95 | 21.95 | 12 | Canada |
| 2000s | 28.87 | 21.36 | 7.51 | Canada |
| 2010s | 25.5 | 23.89 | 1.61 | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in men aged 30-79, Canada or Papua New Guinea?
- Papua New Guinea, at 25.4 against 24.3 in Canada as of 2019.
- What is the difference in prevalence rate of hypertension in men aged 30-79 between Canada and Papua New Guinea?
- 1.1, with Papua New Guinea ahead.
- How many years of comparable data are there for Canada and Papua New Guinea?
- 30 years are reported by both, from 1990 to 2019.
- How do Canada and Papua New Guinea rank globally for prevalence rate of hypertension in men aged 30-79?
- Canada ranks 192nd and Papua New Guinea ranks 189th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in men aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of male population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.